Cochrane Review Group

Pregnancy and Childbirth

252 systematic reviews in Pregnancy and Childbirth ask 3,601 questions. 20.2% have no studies to answer them, 23% rest on very low certainty evidence and 17.6% reach moderate or high certainty.

Reviews
252
Questions
3,601
current versions
No studies
20.2%
Moderate or high
17.6%
No studies 726 · 20.2%Ungraded 421 · 11.7%Very low 828 · 23%Low 993 · 27.6%Moderate 486 · 13.5%High 147 · 4.1%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Magnesium sulphate vs placebo (outcomes
Major neurodevelopmental disability (school age)** · women at risk of preterm birth (< 34 weeks' gestation)
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (2024) · Cochrane
RR 0.92 [0.53, 1.62]2 studies · 940 participantsVery low
Magnesium sulphate vs placebo (outcomes
Breastfeeding at hospital discharge** · women at risk of preterm birth (< 34 weeks' gestation)
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (2024) · Cochrane
no estimate extractedNRNo studies
Magnesium sulphate vs placebo (outcomes
Women’s views of treatment** · women at risk of preterm birth (< 34 weeks' gestation)
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (2024) · Cochrane
no estimate extractedNRNo studies
Summary of findings table ‐ Midwife continuity models vs other models of care
Third or fourth degree tear · childbearing women and their infants (all) (important/secondary outcomes)
Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane
RR 1.1 [0.81, 1.49]7 studies · 9437 participantsVery low
Summary of findings table ‐ Midwife continuity models vs other models of care
Maternal readmission within 28 days · childbearing women and their infants (all) (important/secondary outcomes)
Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane
RR 1.52 [0.78, 2.96]1 study · 1195 participantsVery low
Summary of findings table ‐ Midwife continuity models vs other models of care
Attendance at birth by known midwife · childbearing women and their infants (all) (important/secondary outcomes)
Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane
RR 9.13 [5.87, 14.21]11 studies · 9273 participantsVery low
Summary of findings table ‐ Midwife continuity models vs other models of care
Apgar score less than or equal to 7 at 5 minutes · childbearing women and their infants (all) (important/secondary outcomes)
Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane
RR 0.95 [0.72, 1.24]13 studies · 12806 participantsVery low
Summary of findings table ‐ Midwife continuity models vs other models of care
Fetal loss before 24 weeks gestation · childbearing women and their infants (all) (important/secondary outcomes)
Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane
RR 0.82 [0.67, 1.01]12 studies · 15913 participantsVery low
Summary of findings table ‐ Midwife continuity of care models vs other models of care
Regional analgesia (epidural/spinal) · childbearing women and their infants (all) (critical outcomes)
Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane
RR 0.85 [0.79, 0.92]15 studies · 17754 participantsVery low
Summary of findings table ‐ Midwife continuity of care models vs other models of care
Fetal loss at or after 24 weeks gestation · childbearing women and their infants (all) (critical outcomes)
Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane
RR 1.24 [0.73, 2.13]12 studies · 16122 participantsVery low
Summary of findings table ‐ Midwife continuity of care models vs other models of care
Neonatal death (baby born alive at any gestation and dies within 28 days) · childbearing women and their infants (all) (critical outcomes)
Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane
RR 0.85 [0.43, 1.71]10 studies · 14718 participantsVery low
Summary of findings table ‐ Vitamin B12 supplementation vs placebo/no vitamin B12 supplementation
Maternal anaemia · pregnant women
Vitamin B12 supplementation during pregnancy for maternal and child health outcomes (2024) · Cochrane
RR 1.08 [0.93, 1.26]2 studies · 284 participantsVery low

Reviews 252